Valuation: Astal Laboratories Limited

Market Cap 2.76B 29.26M 25.69M 23.69M 22.17M 41.53M 42.42M 285M 110M 1.36B 110M 107M 4.73B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.48M 26.77M 24.68M 23.1M 43.27M 44.2M 296M 115M 1.42B 114M 112M 4.93B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
38.01%
Yield 2024 *
-
Yield 2025 -
1 day+12.92%
1 week+5.05%
Current month+19.42%
1 month+23.02%
3 months+29.65%
6 months+0.15%
Current year+1.54%
1 week 77.11
Extreme 77.11
91.3
1 month 65.45
Extreme 65.45
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 22.41
Extreme 22.41
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 2023-07-14
Compliance Officer 32 2023-04-18
Director TitleAgeSince
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
+12.92%+5.05%+11.35%+204.31% 40.83M
+7.13%+9.97%+52.48%+163.30% 1,006B
+3.99%+11.50%+67.23%+53.89% 589B
+4.20%+17.03%+36.66%+86.40% 430B
+0.99%+5.11%+29.26%+21.27% 331B
+1.82%+8.85%+39.72%+25.35% 288B
+0.22%+6.98%+32.93%+39.24% 285B
+0.73%+13.51%-26.95%-41.57% 213B
+1.56%+6.14%+27.82%+57.78% 190B
+3.26%+3.33%+20.72%+65.07% 154B
Average +2.15%+5.87%+29.12%+67.50% 348.58B
Weighted average by Cap. +0.59%+5.38%+40.57%+77.68%

Financials

2024 2025
Net sales 237M 2.51M 2.2M 2.03M 1.9M 3.56M 3.64M 24.4M 9.45M 117M 9.42M 9.22M 406M 637M 6.75M 5.93M 5.46M 5.11M 9.58M 9.79M 65.65M 25.42M 314M 25.35M 24.79M 1.09B
Net income 7.85M 83.21K 73.07K 67.36K 63.05K 118K 121K 809K 313K 3.87M 312K 306K 13.46M 89.25M 946K 831K 766K 717K 1.34M 1.37M 9.21M 3.56M 44.06M 3.55M 3.48M 153M
Net Debt -57.64M -611K -537K -495K -463K -868K -886K -5.94M -2.3M -28.45M -2.3M -2.25M -98.89M 115M 1.22M 1.07M 990K 927K 1.74M 1.77M 11.9M 4.61M 56.95M 4.59M 4.49M 198M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
26-06-25 ₹88.19 +12.92% 137,452
26-06-24 ₹78.10 +0.79% 9,030
26-06-23 ₹77.49 -3.98% 24,763
26-06-22 ₹80.70 -1.32% 17,820
26-06-19 ₹81.78 -2.58% 22,681
  1. Stock Market
  2. Stocks
  3. MACINTR Stock